Raphas Co., Ltd. (KOSDAQ:214260)

Market Cap	97.71B -21.8%
Revenue (ttm)	32.16B +13.3%
Net Income	647.72M
EPS	75.61
Shares Out	8.41M
PE Ratio	153.69
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,879
Average Volume	54,026
Open	11,820
Previous Close	n/a
Day's Range	11,570 - 11,880
52-Week Range	11,000 - 21,500
Beta	0.97
RSI	39.57
Earnings Date	Mar 16, 2026

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was incorporated in 2006 and is based in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 79
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2024, Raphas's revenue was 27.22 billion, a decrease of -2.58% compared to the previous year's 27.94 billion. Losses were -4.77 billion, -45.80% less than in 2023.